-
1
-
-
0026584524
-
Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann
-
Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31 (1992) 119-130
-
(1992)
Neurol.
, vol.31
, pp. 119-130
-
-
Beal, M.F.1
-
2
-
-
0002442257
-
Parkinson's disease
-
Koliatsos V.E., and Ratan R.R. (Eds), Humana Press, Totowa, NJ
-
Burke R.E. Parkinson's disease. In: Koliatsos V.E., and Ratan R.R. (Eds). Cell Death and Disease of the Nervous System (1998), Humana Press, Totowa, NJ 459-475
-
(1998)
Cell Death and Disease of the Nervous System
, pp. 459-475
-
-
Burke, R.E.1
-
4
-
-
0035003439
-
Chemistry and biochemistry of oxidative stress in neurodegenerative diseases
-
Sayre L.M., Smith M.A., and Perry G. Chemistry and biochemistry of oxidative stress in neurodegenerative diseases. Curr. Med. Chem. 8 (2001) 721-738
-
(2001)
Curr. Med. Chem.
, vol.8
, pp. 721-738
-
-
Sayre, L.M.1
Smith, M.A.2
Perry, G.3
-
5
-
-
42649144101
-
Oxidative and nitrative protein modifications in Parkinson's disease
-
Danielson S.R., and Andersen J.K. Oxidative and nitrative protein modifications in Parkinson's disease. Free Radic. Biol. Med. 44 (2008) 1787-1794
-
(2008)
Free Radic. Biol. Med.
, vol.44
, pp. 1787-1794
-
-
Danielson, S.R.1
Andersen, J.K.2
-
6
-
-
0022553605
-
Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
-
Perry T.L., and Yong V.W. Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67 (1986) 269-274
-
(1986)
Neurosci. Lett.
, vol.67
, pp. 269-274
-
-
Perry, T.L.1
Yong, V.W.2
-
7
-
-
0032535398
-
Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid mediated neurodegeneration
-
Sriram K., Shankar S.K., Boyd M.R., and Ravindranath V. Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid mediated neurodegeneration. J. Neurosci. 18 (1998) 10287-10296
-
(1998)
J. Neurosci.
, vol.18
, pp. 10287-10296
-
-
Sriram, K.1
Shankar, S.K.2
Boyd, M.R.3
Ravindranath, V.4
-
8
-
-
0034714346
-
Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity: implications for Parkinson's disease
-
Jha N., Jurma O., Lalli G., Liu Y., Pettusi E.H., Greenamyre J.T., Liu R.M., Forman H.J., and Andersen J.K. Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity: implications for Parkinson's disease. J. Biol. Chem. 275 (2000) 26096-27001
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 26096-27001
-
-
Jha, N.1
Jurma, O.2
Lalli, G.3
Liu, Y.4
Pettusi, E.H.5
Greenamyre, J.T.6
Liu, R.M.7
Forman, H.J.8
Andersen, J.K.9
-
9
-
-
0025254401
-
Mitochondrial complex I deficiency in Parkinson's disease
-
Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
-
(1990)
J. Neurochem.
, vol.54
, pp. 823-827
-
-
Schapira, A.H.1
Cooper, J.M.2
Dexter, D.3
Clark, J.B.4
Jenner, P.5
Marsden, C.D.6
-
10
-
-
0037053338
-
Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach
-
Lin T.K., Hughes G., Muratovska A., Blaikie F.H., Brookes P.S., Darley-Usmar V., Smith R.A., and Murphy M.P. Specific modification of mitochondrial protein thiols in response to oxidative stress: a proteomics approach. J. Biol. Chem. 277 (2002) 17048-17056
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 17048-17056
-
-
Lin, T.K.1
Hughes, G.2
Muratovska, A.3
Blaikie, F.H.4
Brookes, P.S.5
Darley-Usmar, V.6
Smith, R.A.7
Murphy, M.P.8
-
11
-
-
0141510019
-
Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry
-
Murray J., Taylor S.W., Zhang B., Ghosh S.S., and Capaldi R.A. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J. Biol. Chem. 278 (2003) 37223-37230
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 37223-37230
-
-
Murray, J.1
Taylor, S.W.2
Zhang, B.3
Ghosh, S.S.4
Capaldi, R.A.5
-
12
-
-
33646948530
-
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled
-
Keeney P.M., Xie J., Capaldi R.A., and Bennett Jr. J.P. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J. Neurosci. 26 (2006) 5256-5264
-
(2006)
J. Neurosci.
, vol.26
, pp. 5256-5264
-
-
Keeney, P.M.1
Xie, J.2
Capaldi, R.A.3
Bennett Jr., J.P.4
-
13
-
-
33846464996
-
Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid
-
Mythri R.B., Jagatha B., Pradhan N., Andersen J., and Bharath M.M. Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria? Antioxid. Redox Signaling 9 (2007) 399-408
-
(2007)
Redox Signaling
, vol.9
, pp. 399-408
-
-
Mythri, R.B.1
Jagatha, B.2
Pradhan, N.3
Andersen, J.4
Bharath, M.M.5
-
14
-
-
9844226198
-
Mitochondrial complex I defects in aging
-
Lenaz G., Bovina C., Castelluccio C., Fato R., Formiggini G., Genova M.L., Marchetti M., Pich M.M., Pallotti F., Parenti Castelli G., and Biagini G. Mitochondrial complex I defects in aging. Mol. Cell. Biochem. 178 (1997) 329-333
-
(1997)
Mol. Cell. Biochem.
, vol.178
, pp. 329-333
-
-
Lenaz, G.1
Bovina, C.2
Castelluccio, C.3
Fato, R.4
Formiggini, G.5
Genova, M.L.6
Marchetti, M.7
Pich, M.M.8
Pallotti, F.9
Parenti Castelli, G.10
Biagini, G.11
-
15
-
-
3042794162
-
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
-
McNaught K.S., Perl D.P., Brownell A.L., and Olanow C.W. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann. Neurol. 56 (2004) 149-162
-
(2004)
Ann. Neurol.
, vol.56
, pp. 149-162
-
-
McNaught, K.S.1
Perl, D.P.2
Brownell, A.L.3
Olanow, C.W.4
-
16
-
-
2442645048
-
Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover
-
Sullivan P.G., Dragicevic N.B., Deng J.H., Bai Y., Dimayuga E., Ding Q., Chen Q., Bruce-Keller A.J., and Keller J.N. Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279 (2004) 20699-20707
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 20699-20707
-
-
Sullivan, P.G.1
Dragicevic, N.B.2
Deng, J.H.3
Bai, Y.4
Dimayuga, E.5
Ding, Q.6
Chen, Q.7
Bruce-Keller, A.J.8
Keller, J.N.9
-
17
-
-
0029981526
-
Neuropathology of Parkinson's disease
-
Forno L.S. Neuropathology of Parkinson's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 259-272
-
(1996)
J. Neuropathol. Exp. Neurol.
, vol.55
, pp. 259-272
-
-
Forno, L.S.1
-
18
-
-
0035975712
-
Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease? Mech
-
Rajagopalan S., and Andersen J.K. Alpha synuclein aggregation: is it the toxic gain of function responsible for neurodegeneration in Parkinson's disease? Mech. Ageing Dev. 122 (2001) 1499-1510
-
(2001)
Ageing Dev.
, vol.122
, pp. 1499-1510
-
-
Rajagopalan, S.1
Andersen, J.K.2
-
19
-
-
33750459730
-
Parkinsonism genes: culprits and clues
-
Abeliovich A., and Beal M.F. Parkinsonism genes: culprits and clues. J. Neurochem. 99 (2006) 1062-1072
-
(2006)
J. Neurochem.
, vol.99
, pp. 1062-1072
-
-
Abeliovich, A.1
Beal, M.F.2
-
20
-
-
33749426753
-
Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease
-
Raichur A., Vali S., and Gorin F. Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease. Neuroscience 142 (2006) 859-870
-
(2006)
Neuroscience
, vol.142
, pp. 859-870
-
-
Raichur, A.1
Vali, S.2
Gorin, F.3
-
21
-
-
33847126974
-
Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis
-
Kaushik P., Gorin F., and Vali S. Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis. J. Comput. Neurosci. 22 (2007) 147-160
-
(2007)
J. Comput. Neurosci.
, vol.22
, pp. 147-160
-
-
Kaushik, P.1
Gorin, F.2
Vali, S.3
-
22
-
-
36249019785
-
Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model
-
Vali S., Mythri R., Jagatha B., Padiadpu J., Ramanujan K.S., Andersen J.K., Gorin F., and Bharath M.M.S. Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson's disease: a dynamic model. Neuroscience 149 (2007) 904-917
-
(2007)
Neuroscience
, vol.149
, pp. 904-917
-
-
Vali, S.1
Mythri, R.2
Jagatha, B.3
Padiadpu, J.4
Ramanujan, K.S.5
Andersen, J.K.6
Gorin, F.7
Bharath, M.M.S.8
-
23
-
-
39149124146
-
Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies
-
Jagatha B., Mythri R.B., Vali S., and Bharath M.M. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies. Free Radic. Biol. Med. 44 (2008) 907-917
-
(2008)
Free Radic. Biol. Med.
, vol.44
, pp. 907-917
-
-
Jagatha, B.1
Mythri, R.B.2
Vali, S.3
Bharath, M.M.4
-
24
-
-
0037366092
-
Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression
-
Dickinson D.A., Iles K.E., Zhang H., Blank V., and Forman H.J. Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB. J. 17 (2003) 473-475
-
(2003)
FASEB. J.
, vol.17
, pp. 473-475
-
-
Dickinson, D.A.1
Iles, K.E.2
Zhang, H.3
Blank, V.4
Forman, H.J.5
-
25
-
-
4644303022
-
Human glutamate cysteine ligase gene regulation through the electrophile response element
-
Dickinson D.A., Levonen A.L., Moellering D.R., Arnold E.K., Zhang H., Darley-Usmar V.M., and Forman H.J. Human glutamate cysteine ligase gene regulation through the electrophile response element. Free Radic. Biol. Med. 37 (2004) 1152-1159
-
(2004)
Free Radic. Biol. Med.
, vol.37
, pp. 1152-1159
-
-
Dickinson, D.A.1
Levonen, A.L.2
Moellering, D.R.3
Arnold, E.K.4
Zhang, H.5
Darley-Usmar, V.M.6
Forman, H.J.7
-
26
-
-
33845442925
-
Mechanistic studies of the Nrf2-Keap1 signaling pathway
-
Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab. Rev. 38 (2006) 769-789
-
(2006)
Drug Metab. Rev.
, vol.38
, pp. 769-789
-
-
Zhang, D.D.1
-
27
-
-
33344469643
-
Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1
-
Kobayashi A., Kang M.I., Watai Y., Tong K.I., Shibata T., Uchida K., and Yamamoto M. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 26 (2006) 221-229
-
(2006)
Mol. Cell. Biol.
, vol.26
, pp. 221-229
-
-
Kobayashi, A.1
Kang, M.I.2
Watai, Y.3
Tong, K.I.4
Shibata, T.5
Uchida, K.6
Yamamoto, M.7
-
28
-
-
0141621061
-
NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons
-
Lee J.M., Shih A.Y., Murphy T.H., and Johnson J.A. NF-E2-related factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular calcium in primary cortical neurons. J. Biol. Chem. 278 (2003) 37948-37956
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 37948-37956
-
-
Lee, J.M.1
Shih, A.Y.2
Murphy, T.H.3
Johnson, J.A.4
-
29
-
-
34648813720
-
ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis
-
D'Autréaux B., and Toledano M.B. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell. Biol. 8 (2007) 813-824
-
(2007)
Nat. Rev. Mol. Cell. Biol.
, vol.8
, pp. 813-824
-
-
D'Autréaux, B.1
Toledano, M.B.2
-
30
-
-
0037064078
-
Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line
-
Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., and Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 277 (2002) 38884-38894
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 38884-38894
-
-
Lotharius, J.1
Barg, S.2
Wiekop, P.3
Lundberg, C.4
Raymon, H.K.5
Brundin, P.6
-
31
-
-
1842454976
-
Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?
-
Sidhu A., Wersinger C., and Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?. FASEB. J. 18 (2004) 637-647
-
(2004)
FASEB. J.
, vol.18
, pp. 637-647
-
-
Sidhu, A.1
Wersinger, C.2
Vernier, P.3
-
32
-
-
1042266326
-
Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective
-
Tanaka M., Kim Y.M., Lee G., Junn E., Iwatsubo T., and Mouradian M.M. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279 (2004) 4625-4631
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 4625-4631
-
-
Tanaka, M.1
Kim, Y.M.2
Lee, G.3
Junn, E.4
Iwatsubo, T.5
Mouradian, M.M.6
-
33
-
-
1842424791
-
Proteasomal inhibition by alpha-synuclein filaments and oligomers
-
Lindersson E., Beedholm R., Højrup P., Moos T., Gai W., Hendil K.B., and Jensen P.H. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J. Biol. Chem. 279 (2004) 12924-12934
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 12924-12934
-
-
Lindersson, E.1
Beedholm, R.2
Højrup, P.3
Moos, T.4
Gai, W.5
Hendil, K.B.6
Jensen, P.H.7
-
34
-
-
0038413759
-
Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function
-
Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., and Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 278 (2003) 11753-11759
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 11753-11759
-
-
Snyder, H.1
Mensah, K.2
Theisler, C.3
Lee, J.4
Matouschek, A.5
Wolozin, B.6
-
35
-
-
0036456584
-
Aggresome-related biogenesis of Lewy bodies
-
McNaught K.S., Shashidharan P., Perl D.P., Jenner P., and Olanow C.W. Aggresome-related biogenesis of Lewy bodies. Eur. J. Neurosci. 16 (2002) 2136-2148
-
(2002)
Eur. J. Neurosci.
, vol.16
, pp. 2136-2148
-
-
McNaught, K.S.1
Shashidharan, P.2
Perl, D.P.3
Jenner, P.4
Olanow, C.W.5
-
36
-
-
44049099669
-
Mitochondrial import and accumulation of alpha-synuclein impairs complex I in human dopaminergic neuronal cultures and Parkinson's disease brain
-
Devi L., Raghavendran V., Prabhu B.M., Avadhani N.G., and Anandatheerthavarada H.K. Mitochondrial import and accumulation of alpha-synuclein impairs complex I in human dopaminergic neuronal cultures and Parkinson's disease brain. J. Biol. Chem. 283 (2008) 9089-9100
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 9089-9100
-
-
Devi, L.1
Raghavendran, V.2
Prabhu, B.M.3
Avadhani, N.G.4
Anandatheerthavarada, H.K.5
-
37
-
-
0033515471
-
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation
-
Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J.C., Wypych J., Biere A.L., and Citron M. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 274 (1999) 9843-9846
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 9843-9846
-
-
Narhi, L.1
Wood, S.J.2
Steavenson, S.3
Jiang, Y.4
Wu, G.M.5
Anafi, D.6
Kaufman, S.A.7
Martin, F.8
Sitney, K.9
Denis, P.10
Louis, J.C.11
Wypych, J.12
Biere, A.L.13
Citron, M.14
-
38
-
-
0034595728
-
Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells
-
Zhou W., Hurlbert M.S., Schaack J., Prasad K.N., and Freed C.R. Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells. Brain Res. 866 (2000) 33-43
-
(2000)
Brain Res.
, vol.866
, pp. 33-43
-
-
Zhou, W.1
Hurlbert, M.S.2
Schaack, J.3
Prasad, K.N.4
Freed, C.R.5
-
39
-
-
0036778280
-
Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy
-
Bharath S., Cochran B.C., Hsu M., Liu J., Ames B.N., and Andersen J.K. Pre-treatment with R-lipoic acid alleviates the effects of GSH depletion in PC12 cells: implications for Parkinson's disease therapy. Neurotoxicology 23 (2002) 479-486
-
(2002)
Neurotoxicology
, vol.23
, pp. 479-486
-
-
Bharath, S.1
Cochran, B.C.2
Hsu, M.3
Liu, J.4
Ames, B.N.5
Andersen, J.K.6
-
40
-
-
0022333202
-
γ-Glutamylcysteine synthetase from erythrocytes
-
Seelig G.F., and Meister A. γ-Glutamylcysteine synthetase from erythrocytes. Methods Enzymol. 113 (1985) 390-392
-
(1985)
Methods Enzymol.
, vol.113
, pp. 390-392
-
-
Seelig, G.F.1
Meister, A.2
-
41
-
-
0029199236
-
Measurement of γ-glutamyl transpeptidase and γ-glutamylcysteine synthetase activities in cells
-
Forman H.J., Shi M.M., Iwamoto T., Liu R.M., and Robison T.W. Measurement of γ-glutamyl transpeptidase and γ-glutamylcysteine synthetase activities in cells. Methods Enzymol. 252 (1995) 66-71
-
(1995)
Methods Enzymol.
, vol.252
, pp. 66-71
-
-
Forman, H.J.1
Shi, M.M.2
Iwamoto, T.3
Liu, R.M.4
Robison, T.W.5
-
42
-
-
0029964226
-
Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines
-
Trounce I.A., Kim Y.L., Jun A.S., and Wallace D.C. Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264 (1996) 484-509
-
(1996)
Methods Enzymol.
, vol.264
, pp. 484-509
-
-
Trounce, I.A.1
Kim, Y.L.2
Jun, A.S.3
Wallace, D.C.4
-
43
-
-
0035870881
-
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis
-
Tanaka Y., Engelender S., Igarashi S., Rao R.K., Wanner T., Tanzi R.E., Sawa A.L., Dawson V., Dawson T.M., and Ross C.A. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10 (2001) 919-926
-
(2001)
Hum. Mol. Genet.
, vol.10
, pp. 919-926
-
-
Tanaka, Y.1
Engelender, S.2
Igarashi, S.3
Rao, R.K.4
Wanner, T.5
Tanzi, R.E.6
Sawa, A.L.7
Dawson, V.8
Dawson, T.M.9
Ross, C.A.10
-
44
-
-
0035109909
-
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult
-
Lee M., Hyun D., Halliwell B., and Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem. 76 (2001) 998-1009
-
(2001)
J. Neurochem.
, vol.76
, pp. 998-1009
-
-
Lee, M.1
Hyun, D.2
Halliwell, B.3
Jenner, P.4
-
45
-
-
15644363581
-
Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells
-
Dick L.R., Cruikshank A.A., Destree A.T., Grenier L., McCormack T.A., Melandri F.D., Nunes S.L., Palombella V.J., Parent L.A., Plamondon L., and Stein R.L. Mechanistic studies on the inactivation of the proteasome by lactacystin in cultured cells. J. Biol. Chem. 272 (1997) 182-188
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 182-188
-
-
Dick, L.R.1
Cruikshank, A.A.2
Destree, A.T.3
Grenier, L.4
McCormack, T.A.5
Melandri, F.D.6
Nunes, S.L.7
Palombella, V.J.8
Parent, L.A.9
Plamondon, L.10
Stein, R.L.11
-
46
-
-
0034595064
-
Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for γ-glutamylcysteine synthetase
-
Sekhar K.R., Soltaninassab S.R., Borrelli M.J., Xu Z.Q., Meredith M.J., Domann F.E., and Freeman M.L. Inhibition of the 26S proteasome induces expression of GLCLC, the catalytic subunit for γ-glutamylcysteine synthetase. Biochem. Biophys. Res. Commun. 270 (2000) 311-317
-
(2000)
Biochem. Biophys. Res. Commun.
, vol.270
, pp. 311-317
-
-
Sekhar, K.R.1
Soltaninassab, S.R.2
Borrelli, M.J.3
Xu, Z.Q.4
Meredith, M.J.5
Domann, F.E.6
Freeman, M.L.7
-
47
-
-
1842424791
-
Proteasomal inhibition by alpha-synuclein filaments and oligomers
-
Lindersson E., Beedholm R., Højrup P., Moos T., Gai W., Hendil K.B., and Jensen P.H. Proteasomal inhibition by alpha-synuclein filaments and oligomers. J. Biol. Chem. 279 (2004) 12924-12934
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 12924-12934
-
-
Lindersson, E.1
Beedholm, R.2
Højrup, P.3
Moos, T.4
Gai, W.5
Hendil, K.B.6
Jensen, P.H.7
-
48
-
-
0038413759
-
Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function
-
Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., and Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6′ proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 278 (2003) 11753-11759
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 11753-11759
-
-
Snyder, H.1
Mensah, K.2
Theisler, C.3
Lee, J.4
Matouschek, A.5
Wolozin, B.6
-
49
-
-
30344481701
-
γ-Glutamyl transpeptidase in glutathione biosynthesis
-
Zhang H., Forman H.J., and Choi J. γ-Glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 401 (2005) 468-483
-
(2005)
Methods Enzymol.
, vol.401
, pp. 468-483
-
-
Zhang, H.1
Forman, H.J.2
Choi, J.3
-
51
-
-
0034604583
-
Wild-type but not Parkinson's disease-related Ala-53→Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli
-
da Costa C.A., Ancolio K., and Checler F. Wild-type but not Parkinson's disease-related Ala-53→Thr mutant alpha-synuclein protects neuronal cells from apoptotic stimuli. J. Biol. Chem. 275 (2000) 24065-24069
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 24065-24069
-
-
da Costa, C.A.1
Ancolio, K.2
Checler, F.3
-
52
-
-
0037185004
-
Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells: abolishment by 6-hydroxydopamine and implications for Parkinson's disease
-
Alves Da Costa C., Paitel E., Vincent B., and Checler F. Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells: abolishment by 6-hydroxydopamine and implications for Parkinson's disease. J. Biol. Chem. 277 (2002) 50980-50984
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 50980-50984
-
-
Alves Da Costa, C.1
Paitel, E.2
Vincent, B.3
Checler, F.4
-
53
-
-
0035109909
-
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult
-
Lee M., Hyun D., Halliwell B., and Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem. 76 (2001) 998-1009
-
(2001)
J. Neurochem.
, vol.76
, pp. 998-1009
-
-
Lee, M.1
Hyun, D.2
Halliwell, B.3
Jenner, P.4
-
54
-
-
0036832421
-
Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway
-
Seo J.H., Rah J.C., Choi S.H., Shin J.K., Min K., Kim H.S., Park C.H., Kim S., Kim E.M., Lee S.H., Lee S., Suh S.W., and Suh Y.H. Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3/Akt kinase pathway. FASEB. J. 16 (2002) 1826-1828
-
(2002)
FASEB. J.
, vol.16
, pp. 1826-1828
-
-
Seo, J.H.1
Rah, J.C.2
Choi, S.H.3
Shin, J.K.4
Min, K.5
Kim, H.S.6
Park, C.H.7
Kim, S.8
Kim, E.M.9
Lee, S.H.10
Lee, S.11
Suh, S.W.12
Suh, Y.H.13
-
55
-
-
0037192865
-
Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells
-
Hashimoto M., Hsu L.J., Rockenstein E., Takenouchi T., Mallory M., and Masliah E. Alpha-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J. Biol. Chem. 277 (2002) 11465-11472
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 11465-11472
-
-
Hashimoto, M.1
Hsu, L.J.2
Rockenstein, E.3
Takenouchi, T.4
Mallory, M.5
Masliah, E.6
-
56
-
-
33745259502
-
Alpha-synuclein is upregulated in neurons in response to chronic oxidative stress and is associated with neuroprotection
-
Quilty M.C., King A.E., Gai W.-P., Pountney D.L., West A.K., Vickers J.C., and Dickson T.C. Alpha-synuclein is upregulated in neurons in response to chronic oxidative stress and is associated with neuroprotection. Exp. Neurol. 199 (2006) 249-256
-
(2006)
Exp. Neurol.
, vol.199
, pp. 249-256
-
-
Quilty, M.C.1
King, A.E.2
Gai, W.-P.3
Pountney, D.L.4
West, A.K.5
Vickers, J.C.6
Dickson, T.C.7
-
57
-
-
0038334899
-
Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration
-
Manning-Bog A.B., McCormack A.L., Purisai M.G., Bolin L.M., and Di Monte D.A. Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration. J. Neurosci. 23 (2003) 3095-3099
-
(2003)
J. Neurosci.
, vol.23
, pp. 3095-3099
-
-
Manning-Bog, A.B.1
McCormack, A.L.2
Purisai, M.G.3
Bolin, L.M.4
Di Monte, D.A.5
-
58
-
-
0037971160
-
Alpha-synuclein protects naïve but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity
-
Jensen P.J., Alter B.J., and O'Malley K.L. Alpha-synuclein protects naïve but not dbcAMP-treated dopaminergic cell types from 1-methyl-4-phenylpyridinium toxicity. J. Neurochem. 86 (2003) 196-209
-
(2003)
J. Neurochem.
, vol.86
, pp. 196-209
-
-
Jensen, P.J.1
Alter, B.J.2
O'Malley, K.L.3
-
59
-
-
0037052633
-
MPP increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells
-
Gómez-Santos C., Ferrer I., Reiriz J., Viñals F., Barrachina M., and Ambrosio S. MPP increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935 (2002) 32-39
-
(2002)
Brain Res.
, vol.935
, pp. 32-39
-
-
Gómez-Santos, C.1
Ferrer, I.2
Reiriz, J.3
Viñals, F.4
Barrachina, M.5
Ambrosio, S.6
-
60
-
-
2442494278
-
Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferring receptor iron and hydrogen peroxide
-
Kalivendi S.V., Cunningham S., Kotamraju S., Joseph J., Hillard C.J., and Kalyanaraman B. Alpha-synuclein up-regulation and aggregation during MPP+-induced apoptosis in neuroblastoma cells: intermediacy of transferring receptor iron and hydrogen peroxide. J. Biol. Chem. 279 (2004) 15240-15247
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 15240-15247
-
-
Kalivendi, S.V.1
Cunningham, S.2
Kotamraju, S.3
Joseph, J.4
Hillard, C.J.5
Kalyanaraman, B.6
-
61
-
-
0032717232
-
Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine
-
Kholodilov N.G., Oo T.F., and Burke R.E. Synuclein expression is decreased in rat substantia nigra following induction of apoptosis by intrastriatal 6-hydroxydopamine. Neurosci. Lett. 275 (1999) 105-108
-
(1999)
Neurosci. Lett.
, vol.275
, pp. 105-108
-
-
Kholodilov, N.G.1
Oo, T.F.2
Burke, R.E.3
-
62
-
-
0032707654
-
Increased expression of α-synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury
-
Kholodilov N.G., Neystat M., Oo T.F., Lo S.E., Larsen K.E., Sulzer D., and Burke R.E. Increased expression of α-synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J. Neurochem. 73 (1999) 2586-2599
-
(1999)
J. Neurochem.
, vol.73
, pp. 2586-2599
-
-
Kholodilov, N.G.1
Neystat, M.2
Oo, T.F.3
Lo, S.E.4
Larsen, K.E.5
Sulzer, D.6
Burke, R.E.7
-
63
-
-
0033405487
-
Alpha synuclein expression in substantia nigra and cortex in Parkinson's disease
-
Neystat M., Lynch T., Przedborski S., Kholodilov N., Rzhetskaya M., and Burke R.E. Alpha synuclein expression in substantia nigra and cortex in Parkinson's disease. Mov. Disord. 14 (1999) 417-422
-
(1999)
Mov. Disord.
, vol.14
, pp. 417-422
-
-
Neystat, M.1
Lynch, T.2
Przedborski, S.3
Kholodilov, N.4
Rzhetskaya, M.5
Burke, R.E.6
-
64
-
-
1042266326
-
Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective
-
Tanaka M., Kim Y.M., Lee G., Junn E., Iwatsubo T., and Mouradian M.M. Aggresomes formed by alpha-synuclein and synphilin-1 are cytoprotective. J. Biol. Chem. 279 (2004) 4625-4631
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 4625-4631
-
-
Tanaka, M.1
Kim, Y.M.2
Lee, G.3
Junn, E.4
Iwatsubo, T.5
Mouradian, M.M.6
-
65
-
-
0242300619
-
alpha-Synuclein locus triplication causes Parkinson's disease
-
Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. alpha-Synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
-
(2003)
Science
, vol.302
, pp. 841
-
-
Singleton, A.B.1
Farrer, M.2
Johnson, J.3
Singleton, A.4
Hague, S.5
Kachergus, J.6
Hulihan, M.7
Peuralinna, T.8
Dutra, A.9
Nussbaum, R.10
Lincoln, S.11
Crawley, A.12
Hanson, M.13
Maraganore, D.14
Adler, C.15
Cookson, M.R.16
Muenter, M.17
Baptista, M.18
Miller, D.19
Blancato, J.20
Hardy, J.21
Gwinn-Hardy, K.22
more..
-
66
-
-
33750459730
-
Parkinsonism genes: culprits and clues
-
Abeliovich A., and Beal M.F. Parkinsonism genes: culprits and clues. J. Neurochem. 99 (2006) 1062-1072
-
(2006)
J. Neurochem.
, vol.99
, pp. 1062-1072
-
-
Abeliovich, A.1
Beal, M.F.2
-
68
-
-
0030882856
-
Alpha-synuclein in Lewy bodies
-
Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., and Goedert M. Alpha-synuclein in Lewy bodies. Nature 388 (1997) 839-840
-
(1997)
Nature
, vol.388
, pp. 839-840
-
-
Spillantini, M.G.1
Schmidt, M.L.2
Lee, V.M.3
Trojanowski, J.Q.4
Jakes, R.5
Goedert, M.6
-
69
-
-
10744221260
-
Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation
-
Gispert S., Del Turco D., Garrett L., Chen A., Bernard D.J., Hamm-Clement J., Korf H.W., Deller T., Braak H., Auburger G., and Nussbaum R.L. Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation. Mol. Cell. Neurosci. 24 (2003) 419-429
-
(2003)
Mol. Cell. Neurosci.
, vol.24
, pp. 419-429
-
-
Gispert, S.1
Del Turco, D.2
Garrett, L.3
Chen, A.4
Bernard, D.J.5
Hamm-Clement, J.6
Korf, H.W.7
Deller, T.8
Braak, H.9
Auburger, G.10
Nussbaum, R.L.11
-
70
-
-
0037173006
-
Human alpha-synuclein-harboring familial Parkinson's disease linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice
-
Lee M.K., Stirling W., Xu Y., Xu X., Qui D., Mandir A.S., Dawson T.M., Copeland N.G., Jenkins N.A., and Price D.L. Human alpha-synuclein-harboring familial Parkinson's disease linked Ala-53 → Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 8968-8973
-
(2002)
Proc. Natl. Acad. Sci. U. S. A.
, vol.99
, pp. 8968-8973
-
-
Lee, M.K.1
Stirling, W.2
Xu, Y.3
Xu, X.4
Qui, D.5
Mandir, A.S.6
Dawson, T.M.7
Copeland, N.G.8
Jenkins, N.A.9
Price, D.L.10
-
71
-
-
0035894855
-
Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death
-
Stefanis L., Larsen K.E., Rideout H.J., Sulzer D., and Greene L.A. Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J. Neurosci. 21 (2001) 9549-9560
-
(2001)
J. Neurosci.
, vol.21
, pp. 9549-9560
-
-
Stefanis, L.1
Larsen, K.E.2
Rideout, H.J.3
Sulzer, D.4
Greene, L.A.5
-
72
-
-
4344659685
-
Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy
-
Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., and Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305 (2004) 1292-1295
-
(2004)
Science
, vol.305
, pp. 1292-1295
-
-
Cuervo, A.M.1
Stefanis, L.2
Fredenburg, R.3
Lansbury, P.T.4
Sulzer, D.5
-
73
-
-
33746533924
-
Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models
-
Cooper A.A., Gitler A.D., Cashikar A., Haynes C.M., Hill K.J., Bhullar B., Liu K., Xu K., Strathearn K.E., Liu F., Cao S., Caldwell K.A., Caldwell G.A., Marsischky G., Kolodner R.D., Labaer J., Rochet J.C., Bonini N.M., and Lindquist S. Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313 (2006) 324-328
-
(2006)
Science
, vol.313
, pp. 324-328
-
-
Cooper, A.A.1
Gitler, A.D.2
Cashikar, A.3
Haynes, C.M.4
Hill, K.J.5
Bhullar, B.6
Liu, K.7
Xu, K.8
Strathearn, K.E.9
Liu, F.10
Cao, S.11
Caldwell, K.A.12
Caldwell, G.A.13
Marsischky, G.14
Kolodner, R.D.15
Labaer, J.16
Rochet, J.C.17
Bonini, N.M.18
Lindquist, S.19
-
74
-
-
20044385568
-
Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein
-
Fornai F., Schluter O.M., Lenzi P., Gesi M., Ruffoli R., Ferrucci M., Lazzeri G., Busceti C.L., Pontarelli F., Battaglia G., Pellegrini A., Nicoletti F., Ruggieri S., Paparelli A., and Sudhof T.C. Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein. Proc. Natl. Acad. Sci. USA 102 (2005) 3413-3418
-
(2005)
Proc. Natl. Acad. Sci. USA
, vol.102
, pp. 3413-3418
-
-
Fornai, F.1
Schluter, O.M.2
Lenzi, P.3
Gesi, M.4
Ruffoli, R.5
Ferrucci, M.6
Lazzeri, G.7
Busceti, C.L.8
Pontarelli, F.9
Battaglia, G.10
Pellegrini, A.11
Nicoletti, F.12
Ruggieri, S.13
Paparelli, A.14
Sudhof, T.C.15
-
75
-
-
25444474703
-
Mitochondria take center stage in aging and neurodegeneration
-
Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58 (2005) 495-505
-
(2005)
Ann. Neurol.
, vol.58
, pp. 495-505
-
-
Beal, M.F.1
-
76
-
-
33644543761
-
Expanding insights of mitochondrial dysfunction in Parkinson's disease
-
Abou-Sleiman P.M., Muqit M.M., and Wood N.W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7 (2006) 207-219
-
(2006)
Nat. Rev. Neurosci.
, vol.7
, pp. 207-219
-
-
Abou-Sleiman, P.M.1
Muqit, M.M.2
Wood, N.W.3
-
77
-
-
29644434199
-
Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity
-
Smith W.W., Jiang H., Pei Z., Tanaka Y., Morita H., Sawa A., Dawson V.L., Dawson T.M., and Ross C.A. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum. Mol. Genet. 14 (2005) 3801-3811
-
(2005)
Hum. Mol. Genet.
, vol.14
, pp. 3801-3811
-
-
Smith, W.W.1
Jiang, H.2
Pei, Z.3
Tanaka, Y.4
Morita, H.5
Sawa, A.6
Dawson, V.L.7
Dawson, T.M.8
Ross, C.A.9
-
78
-
-
0033890821
-
alpha-Synuclein promotes mitochondrial deficit and oxidative stress
-
Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., and Masliah E. alpha-Synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157 (2000) 401-410
-
(2000)
Am. J. Pathol.
, vol.157
, pp. 401-410
-
-
Hsu, L.J.1
Sagara, Y.2
Arroyo, A.3
Rockenstein, E.4
Sisk, A.5
Mallory, M.6
Wong, J.7
Takenouchi, T.8
Hashimoto, M.9
Masliah, E.10
-
79
-
-
1542617769
-
Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP
-
Song D.D., Shults C.W., Sisk A., Rockenstein E., and Masliah E. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186 (2004) 158-172
-
(2004)
Exp. Neurol.
, vol.186
, pp. 158-172
-
-
Song, D.D.1
Shults, C.W.2
Sisk, A.3
Rockenstein, E.4
Masliah, E.5
-
80
-
-
33947513592
-
Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model
-
Norris E.H., Uryu K., Leight S., Giasson B.I., Trojanowski J.Q., and Lee V.M. Pesticide exposure exacerbates alpha-synucleinopathy in an A53T transgenic mouse model. Am. J. Pathol. 170 (2007) 658-666
-
(2007)
Am. J. Pathol.
, vol.170
, pp. 658-666
-
-
Norris, E.H.1
Uryu, K.2
Leight, S.3
Giasson, B.I.4
Trojanowski, J.Q.5
Lee, V.M.6
-
81
-
-
34748826792
-
Localization of alpha-synuclein to mitochondria within midbrain of mice
-
Li W.W., Yang R., Guo J.C., Ren H.M., Zha X.L., Cheng J.S., and Cai D.F. Localization of alpha-synuclein to mitochondria within midbrain of mice. Neuroreport 18 (2007) 1543-1546
-
(2007)
Neuroreport
, vol.18
, pp. 1543-1546
-
-
Li, W.W.1
Yang, R.2
Guo, J.C.3
Ren, H.M.4
Zha, X.L.5
Cheng, J.S.6
Cai, D.F.7
-
82
-
-
0037130174
-
Neurodegenerative disease: amyloid pores from pathogenic mutations
-
Lashuel H.A., Hartley D., Petre B.M., Walz T., and Lansbury Jr. P.T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418 (2002) 291
-
(2002)
Nature
, vol.418
, pp. 291
-
-
Lashuel, H.A.1
Hartley, D.2
Petre, B.M.3
Walz, T.4
Lansbury Jr., P.T.5
-
83
-
-
0038386274
-
Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease
-
Volles M.J., and Lansbury Jr. P.T. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease. Biochemistry 42 (2003) 7871-7878
-
(2003)
Biochemistry
, vol.42
, pp. 7871-7878
-
-
Volles, M.J.1
Lansbury Jr., P.T.2
-
84
-
-
0037072284
-
Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes
-
Ding T.T., Lee S.J., Rochet J.C., and Lansbury Jr. P.T. Annular alpha-synuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes. Biochemistry 41 (2002) 10209-10217
-
(2002)
Biochemistry
, vol.41
, pp. 10209-10217
-
-
Ding, T.T.1
Lee, S.J.2
Rochet, J.C.3
Lansbury Jr., P.T.4
-
85
-
-
0037437192
-
Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells
-
Anandatheerthavarada H.K., Biswas G., Robin M.A., and Avadhani N.G. Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells. J. Cell Biol. 161 (2003) 41-54
-
(2003)
J. Cell Biol.
, vol.161
, pp. 41-54
-
-
Anandatheerthavarada, H.K.1
Biswas, G.2
Robin, M.A.3
Avadhani, N.G.4
-
86
-
-
0141753018
-
Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition
-
Fornai F., Lenzi P., Gesi M., Ferrucci M., Lazzeri G., Busceti C.L., Ruffoli R., Soldani P., Ruggieri S., Alessandri M.G., and Paparelli A. Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. J. Neurosci. 23 (2003) 8955-8966
-
(2003)
J. Neurosci.
, vol.23
, pp. 8955-8966
-
-
Fornai, F.1
Lenzi, P.2
Gesi, M.3
Ferrucci, M.4
Lazzeri, G.5
Busceti, C.L.6
Ruffoli, R.7
Soldani, P.8
Ruggieri, S.9
Alessandri, M.G.10
Paparelli, A.11
-
87
-
-
0037469979
-
Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons
-
Kikuchi S., Shinpo K., Tsuji S., Takeuchi M., Yamagishi S., Makita Z., Niino M., Yabe I., and Tashiro K. Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons. Brain Res. 964 (2003) 228-236
-
(2003)
Brain Res.
, vol.964
, pp. 228-236
-
-
Kikuchi, S.1
Shinpo, K.2
Tsuji, S.3
Takeuchi, M.4
Yamagishi, S.5
Makita, Z.6
Niino, M.7
Yabe, I.8
Tashiro, K.9
-
88
-
-
13844272420
-
4-Hydroxynonenal increases γ-glutamyl transpeptidase gene expression through mitogen-activated protein kinase pathways
-
Zhang H., Dickinson D.A., Liu R.M., and Forman H.J. 4-Hydroxynonenal increases γ-glutamyl transpeptidase gene expression through mitogen-activated protein kinase pathways. Free Radic. Biol. Med. 38 (2005) 463-471
-
(2005)
Free Radic. Biol. Med.
, vol.38
, pp. 463-471
-
-
Zhang, H.1
Dickinson, D.A.2
Liu, R.M.3
Forman, H.J.4
-
89
-
-
0036802703
-
4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells
-
Dickinson D.A., Iles K.E., Watanabe N., Iwamoto T., Zhang H., Krzywanski D.M., and Forman H.J. 4-Hydroxynonenal induces glutamate cysteine ligase through JNK in HBE1 cells. Free Radic. Biol. Med. 33 (2002) 974
-
(2002)
Free Radic. Biol. Med.
, vol.33
, pp. 974
-
-
Dickinson, D.A.1
Iles, K.E.2
Watanabe, N.3
Iwamoto, T.4
Zhang, H.5
Krzywanski, D.M.6
Forman, H.J.7
|